
Khatol S. Shahnan Shah
Examiner (ID: 11599, Phone: (571)272-0863 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 690 |
| Issued Applications | 341 |
| Pending Applications | 102 |
| Abandoned Applications | 265 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8406435
[patent_doc_number] => 20120238504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-20
[patent_title] => 'Stable Formulations of Botulinum Toxin in Hydrogels'
[patent_app_type] => utility
[patent_app_number] => 13/440162
[patent_app_country] => US
[patent_app_date] => 2012-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12058
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13440162
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/440162 | Stable Formulations of Botulinum Toxin in Hydrogels | Apr 4, 2012 | Abandoned |
Array
(
[id] => 8767468
[patent_doc_number] => 20130095505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'DETECTION OF LIPID OXIDISING ABZYMES IN SAMPLES'
[patent_app_type] => utility
[patent_app_number] => 13/439927
[patent_app_country] => US
[patent_app_date] => 2012-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6565
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13439927
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/439927 | DETECTION OF LIPID OXIDISING ABZYMES IN SAMPLES | Apr 4, 2012 | Abandoned |
Array
(
[id] => 9268767
[patent_doc_number] => 20140023684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-23
[patent_title] => 'Vaccine Against Pasteurellaceae'
[patent_app_type] => utility
[patent_app_number] => 14/008935
[patent_app_country] => US
[patent_app_date] => 2012-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12253
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008935
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/008935 | Vaccine Against Pasteurellaceae | Mar 29, 2012 | Abandoned |
Array
(
[id] => 10149033
[patent_doc_number] => 09181308
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-10
[patent_title] => 'Methods and compositions employing immunogenic fusion proteins'
[patent_app_type] => utility
[patent_app_number] => 14/007159
[patent_app_country] => US
[patent_app_date] => 2012-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 24979
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14007159
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/007159 | Methods and compositions employing immunogenic fusion proteins | Mar 22, 2012 | Issued |
Array
(
[id] => 9685347
[patent_doc_number] => 20140242111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'Engineered Bacteria for Oral Delivery of Glucoregulatory Proteins'
[patent_app_type] => utility
[patent_app_number] => 14/003596
[patent_app_country] => US
[patent_app_date] => 2012-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14392
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14003596
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/003596 | Engineered bacteria for oral delivery of glucoregulatory proteins | Mar 7, 2012 | Issued |
Array
(
[id] => 9330503
[patent_doc_number] => 20140057285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'COMPOSITIONS AND METHODS TARGETING FORCE GENERATION IN KINESIN'
[patent_app_type] => utility
[patent_app_number] => 14/003070
[patent_app_country] => US
[patent_app_date] => 2012-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 17143
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14003070
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/003070 | COMPOSITIONS AND METHODS TARGETING FORCE GENERATION IN KINESIN | Mar 4, 2012 | Abandoned |
Array
(
[id] => 9204964
[patent_doc_number] => 20140004142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'PCSK9 VACCINE'
[patent_app_type] => utility
[patent_app_number] => 14/002505
[patent_app_country] => US
[patent_app_date] => 2012-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 54
[patent_no_of_words] => 34058
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14002505
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/002505 | PCSK9 VACCINE | Feb 27, 2012 | Abandoned |
Array
(
[id] => 8371099
[patent_doc_number] => 20120220490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'METHOD AND COMPOSITIONS FOR DETECTING BOTULINUM NEUROTOXIN'
[patent_app_type] => utility
[patent_app_number] => 13/403603
[patent_app_country] => US
[patent_app_date] => 2012-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15552
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13403603
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/403603 | Method and compositions for detecting botulinum neurotoxin | Feb 22, 2012 | Issued |
Array
(
[id] => 9756723
[patent_doc_number] => 20140287424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'SLIDE CHIP FOR DETECTION SENSOR OF FOOD-BORNE PATHOGENS AND PREPARATION METHOD THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/343213
[patent_app_country] => US
[patent_app_date] => 2012-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2644
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14343213
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/343213 | Slide chip for detection sensor of food-borne pathogens and preparation method thereof | Feb 21, 2012 | Issued |
Array
(
[id] => 11388743
[patent_doc_number] => 09549974
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-24
[patent_title] => 'Method for selecting and producing vaccine components and vaccines based thereon'
[patent_app_type] => utility
[patent_app_number] => 13/397354
[patent_app_country] => US
[patent_app_date] => 2012-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 19
[patent_no_of_words] => 17137
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13397354
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/397354 | Method for selecting and producing vaccine components and vaccines based thereon | Feb 14, 2012 | Issued |
Array
(
[id] => 9190980
[patent_doc_number] => 20130330295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-12
[patent_title] => 'ANTIGENIC GLY1 POLYPEPTIDE'
[patent_app_type] => utility
[patent_app_number] => 13/981404
[patent_app_country] => US
[patent_app_date] => 2012-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7109
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13981404
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/981404 | ANTIGENIC GLY1 POLYPEPTIDE | Feb 6, 2012 | Abandoned |
Array
(
[id] => 11343511
[patent_doc_number] => 09527905
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-27
[patent_title] => 'Antibodies that specifically bind Staphylococcus aureus alpha toxin and methods of use'
[patent_app_type] => utility
[patent_app_number] => 13/983804
[patent_app_country] => US
[patent_app_date] => 2012-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 32
[patent_no_of_words] => 50661
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13983804
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/983804 | Antibodies that specifically bind Staphylococcus aureus alpha toxin and methods of use | Feb 6, 2012 | Issued |
Array
(
[id] => 10587702
[patent_doc_number] => 09309305
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-12
[patent_title] => 'Anti-ricin antibodies and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/122366
[patent_app_country] => US
[patent_app_date] => 2012-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 14547
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14122366
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/122366 | Anti-ricin antibodies and uses thereof | Jan 30, 2012 | Issued |
Array
(
[id] => 12199889
[patent_doc_number] => 09902947
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-27
[patent_title] => 'CyaA-carried polypeptide(s) and use to induce both therapeutic and prophylactic immune responses'
[patent_app_type] => utility
[patent_app_number] => 13/981250
[patent_app_country] => US
[patent_app_date] => 2012-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 20
[patent_no_of_words] => 17413
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13981250
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/981250 | CyaA-carried polypeptide(s) and use to induce both therapeutic and prophylactic immune responses | Jan 23, 2012 | Issued |
Array
(
[id] => 9205002
[patent_doc_number] => 20140004178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'OMV VACCINE AGAINST BURKHOLDERIA INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 13/979037
[patent_app_country] => US
[patent_app_date] => 2012-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 36548
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13979037
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/979037 | OMV VACCINE AGAINST BURKHOLDERIA INFECTIONS | Jan 11, 2012 | Abandoned |
Array
(
[id] => 9197658
[patent_doc_number] => 20130336974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'METHOD FOR DELIVERING AGENTS INTO CELLS USING BACTERIAL TOXINS'
[patent_app_type] => utility
[patent_app_number] => 13/978550
[patent_app_country] => US
[patent_app_date] => 2012-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9364
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13978550
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/978550 | Method for delivering agents into cells using bacterial toxins | Jan 9, 2012 | Issued |
Array
(
[id] => 9936889
[patent_doc_number] => 08986695
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-24
[patent_title] => 'Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB—SauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5'
[patent_app_type] => utility
[patent_app_number] => 13/298966
[patent_app_country] => US
[patent_app_date] => 2011-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11238
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13298966
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/298966 | Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB—SauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5 | Nov 16, 2011 | Issued |
Array
(
[id] => 10070696
[patent_doc_number] => 09109040
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-18
[patent_title] => 'Treatment and prevention of malaria'
[patent_app_type] => utility
[patent_app_number] => 13/884604
[patent_app_country] => US
[patent_app_date] => 2011-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 20732
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884604
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/884604 | Treatment and prevention of malaria | Nov 7, 2011 | Issued |
Array
(
[id] => 10077362
[patent_doc_number] => 09115205
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-25
[patent_title] => 'Plasmodium falciparum circumsporozoite vaccine gene optimization for soluble protein expression'
[patent_app_type] => utility
[patent_app_number] => 13/880227
[patent_app_country] => US
[patent_app_date] => 2011-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 20
[patent_no_of_words] => 13056
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13880227
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/880227 | Plasmodium falciparum circumsporozoite vaccine gene optimization for soluble protein expression | Oct 17, 2011 | Issued |
Array
(
[id] => 11772486
[patent_doc_number] => 09381241
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-05
[patent_title] => 'Mucosal adjuvant composition'
[patent_app_type] => utility
[patent_app_number] => 13/876439
[patent_app_country] => US
[patent_app_date] => 2011-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 7465
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13876439
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/876439 | Mucosal adjuvant composition | Sep 26, 2011 | Issued |